isoxazoles has been researched along with Graft vs Host Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 11 (64.71) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botelho-Nevers, E; Gagneux-Brunon, A; Laurent, B; Lucht, F; Mariat, C; Michalet, M; Pillet, S | 1 |
| Chen, P; Fung, H; Gu, Y; He, S; Hexner, E; Hu, S; Huang, J; Huang, Q; Jin, J; Jin, M; Li, C; Liu, Y; Ma, A; Reshef, R; Tian, Y; Tong, Q; Yu, H; Zhang, Y | 1 |
| He, C; Liu, S; Lu, X; Luo, P; Wu, M; Yan, Z; Yu, Y | 1 |
| Avery, RK; Bolwell, BJ; Curtis, J; Kalaycio, M; Kohn, D; Long, JR; Longworth, DL; Lurain, N; Mossad, SB; Pohlman, B; Taege, AJ; Waldman, WJ; Williams, JW; Yen-Lieberman, B | 1 |
| Bartlett, RR; Langer, KH; Mrowka, C; Thoenes, GH | 1 |
| Chong, AS; Cohn, S; Foster, PF; Kociss, K; McChesney, L; Sankary, HN; Williams, JW; Xiao, F | 1 |
| Bartlett, RR; Brendel, S; Schorlemmer, HU | 1 |
| Bartlett, RR; Kurrle, R; Schorlemmer, HU | 3 |
| Kurrle, R; Ruuth, E; Schorlemmer, HU | 1 |
| Gregory, CR; Hou, SM; Jeng, CR; Lai, YC; Lui, LT; Yeh, LS | 1 |
| Bartlett, RR; Schorlemmer, HU | 1 |
| Schorlemmer, HU | 1 |
| Bartlett, RR; Bremer, E; Dimitrijevic, M; Germann, T; Küchle, CC; Mattar, T; Rüde, E; Schorlemmer, HU; Thoenes, GH; Zielinski, T | 1 |
| Bartlett, RR; Popovic, S | 1 |
2 review(s) available for isoxazoles and Graft vs Host Disease
| Article | Year |
|---|---|
Development of a novel drug for transplantation: current results and future perspectives.
Topics: Alkynes; Aniline Compounds; Animals; Autoimmune Diseases; Biological Availability; Crotonates; Drug Design; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Heart Transplantation; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Nitriles; Skin Transplantation; Toluidines; Transplantation, Homologous | 2001 |
Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Disease Models, Animal; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Molecular Sequence Data | 1991 |
15 other study(ies) available for isoxazoles and Graft vs Host Disease
| Article | Year |
|---|---|
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Myelodysplastic Syndromes; Plasmapheresis; Polyomavirus Infections; Renal Insufficiency, Chronic; Tumor Virus Infections; Viral Load; Viremia; Virus Activation | 2015 |
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
Topics: Animals; Enhancer of Zeste Homolog 2 Protein; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Histones; HSP90 Heat-Shock Proteins; Indoles; Isoxazoles; Lysine; Methylation; Mice, Inbred BALB C; Mice, Inbred C57BL; Minor Histocompatibility Antigens; Protein Domains; Protein Stability; Pyridones; Resorcinols; T-Lymphocytes; Transplantation, Homologous | 2017 |
Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice.
Topics: Animals; Antigen-Antibody Complex; Ascites; Cell Proliferation; Disease Models, Animal; Female; Graft vs Host Disease; Immunity, Innate; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Longevity; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Signal Transduction; Spleen; Toll-Like Receptor 9 | 2012 |
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Middle Aged; Salvage Therapy; Transplantation, Homologous; Viral Load | 2004 |
Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide.
Topics: Acute Disease; Animals; Conjunctivitis; Dermatitis; Graft vs Host Disease; Hybridization, Genetic; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver; Male; Rats; Rats, Inbred Lew; Spleen | 1994 |
Leflunomide immunosuppression in rat small intestinal transplantation.
Topics: Animals; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Leflunomide; Rats; Rats, Inbred Lew; Transplantation, Homologous; Weight Gain | 1994 |
Malononitrilamides prevent the development of murine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/lpr autoimmune mice.
Topics: Aging; Alkynes; Animals; Antibody Formation; Crosses, Genetic; Disease Models, Animal; Female; Graft vs Host Disease; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Lupus Erythematosus, Systemic; Mice; Mice, Inbred DBA; Mice, Mutant Strains; Nitriles | 1996 |
Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
Topics: Alkynes; Animals; Graft vs Host Disease; Graft vs Host Reaction; Immunosuppressive Agents; Isoxazoles; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Nitriles; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Spleen; Splenomegaly; Time Factors; Transplantation, Homologous | 1996 |
Various graft vs. host diseases (GvHD) in rodents can be prevented and treated by malononitrilamides (MNAs).
Topics: Alkynes; Animals; Graft vs Host Disease; Immunosuppressive Agents; Isoxazoles; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1997 |
The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
Topics: Alkynes; Animals; Disease Models, Animal; Graft vs Host Disease; Graft vs Host Reaction; Immunosuppressive Agents; Isoxazoles; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1997 |
Regulation of alloreactivity in the popliteal lymph node assay by the new immunosuppressants: malononitrilamides.
Topics: Alkynes; Animals; Graft vs Host Disease; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Lymph Nodes; Nitriles; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1998 |
Irradiation or temporal variations in immunosuppressive schedules do not prevent graft-versus-host disease following rat limb allotransplantation.
Topics: Animals; Cyclosporine; Drug Administration Schedule; Extremities; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1998 |
Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamides.
Topics: Acrylamide; Acrylamides; Alkynes; Animals; Antibody Formation; Autoantibodies; Autoimmune Diseases; Caproates; Crosses, Genetic; Female; Glomerulonephritis; Graft vs Host Disease; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Nitriles; Spleen; Transplantation, Homologous | 1998 |
Leflunomide. Arava, HWA 486, SU 101.
Topics: Animals; Dogs; Drugs, Investigational; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Kidney Transplantation; Leflunomide; Lung Transplantation; Mice; Rats; Skin Transplantation | 1999 |
The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Graft vs Host Disease; Indomethacin; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mice; Prednisolone | 1987 |